Načítá se...
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Since December 2019, a novel type of coronavirus disease (COVID-19) in Wuhan led to an outbreak throughout China and the rest of the world. To date, there have been more than 1,260,000 COVID-19 patients, with a mortality rate of approximately 5.44%. Studies have shown that coagulation dysfunction is...
Uloženo v:
| Vydáno v: | Mil Med Res |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7167301/ https://ncbi.nlm.nih.gov/pubmed/32307014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40779-020-00247-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|